KALA BIO (KALA) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free KALA Stock Alerts $6.50 +0.17 (+2.69%) (As of 04/23/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability KALA BIO Short Interest DataCurrent Short Volume6,000 sharesPrevious Short Volume12,100 sharesChange Vs. Previous Month-50.41%Dollar Volume Sold Short$47,820.00Short Interest Ratio / Days to Cover0.2Last Record DateMarch 31, 2024Outstanding Shares2,820,000 sharesFloat Size2,420,000 sharesShort Percent of Float0.25%Today's Trading Volume5,284 sharesAverage Trading Volume13,275 sharesToday's Volume Vs. Average40% Short Selling KALA BIO ? Sign up to receive the latest short interest report for KALA BIO and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKALA Short Interest Over TimeKALA Days to Cover Over TimeKALA Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry KALA BIO Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20246,000 shares $47,820.00 -50.4%0.3%0.2 $7.97 3/15/202412,100 shares $91,113.00 +22.2%0.5%0.4 $7.53 2/29/20249,900 shares $71,082.00 -18.2%0.4%0.2 $7.18 2/15/202412,100 shares $86,999.00 -28.4%0.5%0.1 $7.19 1/31/202416,900 shares $117,455.00 -50.2%0.8%0.2 $6.95 1/15/202433,900 shares $272,895.00 +20.2%1.6%0.4 $8.05 Get the Latest News and Ratings for KALA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KALA BIO and its competitors with MarketBeat's FREE daily newsletter. 12/31/202328,200 shares $197,400.00 -61.6%1.4%0.4 $7.00 12/15/202373,500 shares $498,330.00 +34.9%3.4%1.1 $6.78 11/30/202354,500 shares $329,725.00 -14.0%2.6%0.8 $6.05 11/15/202363,400 shares $334,752.00 +0.2%3.0%3.6 $5.28 10/31/202363,300 shares $430,440.00 -15.8%3.2%3.3 $6.80 10/15/202375,200 shares $614,376.48 -24.8%3.8%3 $8.17 9/30/2023100,000 shares $890,000.00 +48.4%4.9%3.2 $8.90 9/15/202367,400 shares $716,462.00 +632.6%3.3%1.7 $10.63 8/31/20239,200 shares $123,464.00 -87.8%0.5%0.2 $13.42 8/15/202375,500 shares $1.03 million -18.6%3.8%1.2 $13.70 7/31/202392,800 shares $1.39 million -51.0%4.6%1.2 $15.03 7/15/2023189,400 shares $2.73 million -0.7%10.2%2.2 $14.43 6/30/2023190,800 shares $2.78 million +34.0%10.3%1.6 $14.59 6/15/2023142,400 shares $2.10 million -4.9%7.8%1 $14.73 5/31/2023149,800 shares $2.14 million -20.1%7.5%0.7 $14.30 5/15/2023187,500 shares $3.13 million +12.6%9.4%0.3 $16.67 4/30/2023166,500 shares $2.63 million -3.1%10.0%0.3 $15.77 4/15/2023171,900 shares $2.86 million -32.9%10.4%0.2 $16.63 3/31/2023256,200 shares $3.86 million +29.5%15.4%0.3 $15.05 3/15/2023197,800 shares $3.30 million -20.6%12.4%0.1 $16.69 2/28/2023249,100 shares $2.52 million +16.6%18.5%0.1 $10.13 2/15/2023213,600 shares $2.73 million -29.6%15.4%0.1 $12.78 1/31/2023303,200 shares $5.26 million +28.3%22.6%0.1 $17.34 1/15/2023236,300 shares $4.64 million -52.2%17.6%0.1 $19.62 12/30/2022494,700 shares $18.87 million +389.3%38.4%0.2 $38.15 12/15/2022101,100 shares $442,818.00 +5.4%7.8%0.5 $4.38 11/30/202295,900 shares $507,311.00 +25.2%7.5%0.5 $5.29 11/15/202276,600 shares $491,772.00 +74.5%6.0%0.5 $6.42 10/31/202243,900 shares $278,765.00 +32.6%3.9%0.3 $6.35 10/15/202233,100 shares $415,405.00 -97.9%N/A1.2 $12.55 9/30/20221,610,000 shares $356,454.00 -13.0%2.7%1.6 $0.22 9/15/20221,850,000 shares $626,780.00 -11.9%3.1%1.4 $0.34 8/31/20222,100,000 shares $638,400.00 +1.9%3.5%1.4 $0.30 8/15/20222,060,000 shares $683,302.00 +13.2%3.4%1.1 $0.33This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry KALA Short Interest - Frequently Asked Questions What is KALA BIO's current short interest? Short interest is the volume of KALA BIO shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 6,000 shares of KALA short. 0.25% of KALA BIO's shares are currently sold short. Learn More on KALA BIO's current short interest. What is a good short interest percentage for KALA BIO? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.25% of KALA BIO's floating shares are currently sold short. Is KALA BIO's short interest increasing or decreasing? KALA BIO saw a decline in short interest in March. As of March 31st, there was short interest totaling 6,000 shares, a decline of 50.4% from the previous total of 12,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is KALA BIO's float size? KALA BIO currently has issued a total of 2,820,000 shares. Some of KALA BIO's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. KALA BIO currently has a public float of 2,420,000 shares. How does KALA BIO's short interest compare to its competitors? 0.25% of KALA BIO's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to KALA BIO: FSD Pharma Inc. (2.06%), NeuroSense Therapeutics Ltd. (0.70%), Flora Growth Corp. (13.36%), Orgenesis Inc. (0.87%), Benitec Biopharma Inc. (0.47%), Minerva Neurosciences, Inc. (0.74%), Galecto, Inc. (0.16%), Alaunos Therapeutics, Inc. (9.90%), VBI Vaccines Inc. (1.30%), BioVie Inc. (3.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short KALA BIO stock? Short selling KALA is an investing strategy that aims to generate trading profit from KALA BIO as its price is falling. KALA shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against KALA BIO? A short squeeze for KALA BIO occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KALA, which in turn drives the price of the stock up even further. How often is KALA BIO's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KALA, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: FSD Pharma Short Squeeze NeuroSense Therapeutics Short Squeeze Flora Growth Short Squeeze Orgenesis Short Squeeze Benitec Biopharma Short Squeeze Minerva Neurosciences Short Squeeze Galecto Short Squeeze Alaunos Therapeutics Short Squeeze VBI Vaccines Short Squeeze BioVie Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KALA) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing